Managing menopausal symptoms

American Journal of Nursing

Volumn 112, Issue 6, 2012, Pages 28-35

  Roush, Karen ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANXIETY DISORDER; DEPRESSION; FEMALE; HOT FLUSH; HUMAN; INSOMNIA; MENOPAUSE; MIDDLE AGED; MOOD DISORDER; NURSING; PSYCHOLOGICAL ASPECT; REVIEW;

AGED; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; MOOD DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84862187364     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000415120.76982.7a     Document Type: Review

References (90)

1. Shanafelt TD, et al. Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002;77(11):1207-18. (Pubitemid 35266369)
2. Blumel JE, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18(7):778-85.
3. Williams RE, et al. Frequency and severity of vasomotor symptoms among peri-and postmenopausal women in the United States. Climacteric 2008;11(1):32-43.
4. Col N F, et al. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 2009;16(3):453-7.
5. Guthrie JR, et al. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7(4):375-89. (Pubitemid 40018330)
6. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005;118 Suppl 12B:14-24.
7. Politi MC, et al. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008; 23(9):1507-13.
8. Freeman E W, et al. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Womens Health Gend Based Med 2001;10(1):67-76. (Pubitemid 32229475)
9. Gold EB, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006;96(7):1226-35. (Pubitemid 43967848)
10. Whiteman MK, et al. Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) 2003;12(5):459-72. (Pubitemid 36874087)
11. Green R, Santoro N. Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond Engl) 2009;5(2):127-33.
12. Thurston RC, et al. Adiposity and reporting of vasomotor symptoms among midlife women: the Study of Women's Health Across the Nation. Am J Epidemiol 2008;167(1):78-85.
13. Thurston RC, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15(3):429-34. (Pubitemid 351656746)
14. Gold EB, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004; 159(12):1189-99. (Pubitemid 38747266)
15. Ziv-Gal A, Flaws JA. Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health (Larchmt) 2010;19(10):1905-14.
16. Moilanen J, et al. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas 2010;67(4):368-74.
17. Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005;118 Suppl 12B:148-54.
18. Woods N F, et al. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 2006;13(6):902-10. (Pubitemid 44760382)
19. Crandall CJ, et al. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med 2006;119(9 Suppl 1):S52-S60. (Pubitemid 44292103)
20. Joffe H, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9(6):392-8. (Pubitemid 36706332)
21. Lermer MA, et al. Somatic and affective anxiety symptoms and menopausal hot flashes. Menopause 2011;18(2):129-32.
22. Lu S Y, et al. Factors related to depression during menopause: a study in southern Taiwan. J Nurs Res 2009;17(2):128-35.
23. Seritan AL, et al. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause 2010; 17(2):410-5.
24. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause 2010; 17(2):242-55.
25. Loprinzi CL, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 2009;27(17):2831-7.
26. Freeman E W, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA 2011;305(3):267-74.
27. Arroll B, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 2005; 3(5):449-56. (Pubitemid 41512663)
28. MacGillivray S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 2003;326(7397):1014.
29. Butt DA, et al. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause 2008; 15(2):310-8. (Pubitemid 351354993)
30. Guttuso T, Jr., et al. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101(2):337-45. (Pubitemid 36170136)
31. Lethaby AE, et al. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2007(4): CD001395.
32. Bolanos R, et al. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause 2010;17(3):660-6.
33. Geller SE, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16(6):1156-66.
34. Nelson HD, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006; 295(17):2057-71. (Pubitemid 44794007)
35. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res 2008;58(1):8-14.
36. Shams T, et al. Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis. Altern Ther Health Med 2010;16(1):36-44.
37. Cho SH, Whang WW. Acupuncture for vasomotor menopausal symptoms: a systematic review. Menopause 2009;16(5):1065-73.
38. Birch S. Controlling for non-specific effects of acupuncture in clinical trials. Clinical acupuncture and oriental medicine 2003;4(2-3):59-70. (Pubitemid 37455734)
39. Venzke L, et al. A randomized trial of acupuncture for vasomotor symptoms in post-menopausal women. Complement Ther Med 2010;18(2):59-66.
40. Borud EK, et al. The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial. Menopause 2009;16(3):484-93.
41. Kim KH, et al. Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women - a multicenter randomized clinical trial. Menopause 2010;17(2):269-80.
42. Daley AJ, et al. Exercise to reduce vasomotor and other menopausal symptoms: a review. Maturitas 2009;63(3):176-80.
43. Daley A, et al. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2011(5): CD006108.
44. Kravitz HM, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10(1):19-28. (Pubitemid 36706318)
45. Tom SE, et al. Self-reported sleep difficulty during the menopausal transition: results from a prospective cohort study. Menopause 2010;17(6):1128-35.
46. Bixler EO, et al. Women sleep objectively better than men and the sleep of young women is more resilient to external stressors: effects of age and menopause. J Sleep Res 2009;18(2):221-8.
47. Hachul H, et al. Does the reproductive cycle influence sleep patterns in women with sleep complaints? Climacteric 2010; 13(6):594-603.
48. Xu M, et al. Comparison of subjective and objective sleep quality in menopausal and non-menopausal women with insomnia. Sleep Med 2011;12(1):65-9.
49. Roth T, et al. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep 2005;28(3):303-7. (Pubitemid 40315565)
50. Bolge SC, et al. Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause 2010;17(1): 80-6.
51. LeBlanc M, et al. Psychological and health-related quality of life factors associated with insomnia in a population-based sample. J Psychosom Res 2007;63(2):157-66. (Pubitemid 47088553)
52. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007;14(5):826-9. (Pubitemid 47517578)
53. O'Connor G T, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009;179(12):1159-64.
54. Young T, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31(8):1071-8.
55. Bixler EO, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163(3 Pt 1):608-13. (Pubitemid 32230817)
56. Young T, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003;167(9):1181-5. (Pubitemid 36555088)
57. Polo-Kantola P, et al. Estrogen replacement therapy and nocturnal periodic limb movements: a randomized controlled trial. Obstet Gynecol 2001;97(4):548-54.
58. Arakane M, et al. Factors relating to insomnia during the menopausal transition as evaluated by the Insomnia Severity Index. Maturitas 2011;69(2):157-61.
59. Chedraui P, et al. Factors related to increased daytime sleepiness during the menopausal transition as evaluated by the Epworth sleepiness scale. Maturitas 2010;65(1):75-80.
60. Edinger JD, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. Sleep 2009;32(4):499-510.
61. Irwin MR, et al. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 2006;25(1):3-14. (Pubitemid 43214376)
62. Morin CM, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006;29(11):1398-414. (Pubitemid 44764665)
63. Yang CM, et al. Maladaptive sleep hygiene practices in good sleepers and patients with insomnia. J Health Psychol 2010; 15(1):147-55.
64. van Straten A, Cuijpers P. Self-help therapy for insomnia: a meta-analysis. Sleep Med Rev 2009;13(1):61-71.
65. Buscemi N, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007;22(9):1335-50. (Pubitemid 47247294)
66. Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev 2011;15(2):99-106.
67. Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 2010;14(5):329-37.
68. Hachul H, et al. Isoflavones decrease insomnia in postmenopause. Menopause 2011;18(2):178-84.
69. van Geijlswijk IM, et al. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep 2010; 33(12):1605-14.
70. Bromberger JT, et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007;103(1-3):267-72. (Pubitemid 47445776)
71. Cohen LS, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63(4):385-90.
72. Freeman EW, et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63(4):375-82.
73. Tangen T, Mykletun A. Depression and anxiety through the climacteric period: an epidemiological study (HUNT-II). J Psychosom Obstet Gynaecol 2008;29(2):125-31. (Pubitemid 351873842)
74. Woods NF, et al. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2008;15(2):223-32. (Pubitemid 351354981)
75. Deecher D, et al. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008;33(1):3-17.
76. Greendale GA, et al. Menopause-associated symptoms and cognitive performance: results from the Study of Women's Health Across the Nation. Am J Epidemiol 2010;171(11): 1214-24.
77. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4(1):31-47. (Pubitemid 8066015)
78. Avis NE, et al. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4(3):243-9. (Pubitemid 32896914)
79. Zervas IM, et al. Additive effect of depressed mood and vasomotor symptoms on postmenopausal insomnia. Menopause 2009;16(4):837-42.
80. Burleson MH, et al. Daily vasomotor symptoms, sleep problems, and mood: using daily data to evaluate the domino hypothesis in middle-aged women. Menopause 2010;17(1):87-95.
81. Joffe H, et al. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause 2009;16(4):671-9.
82. Hickey M, et al. Evaluation and management of depressive and anxiety symptoms in midlife. Climacteric 2012;15(1):3-9.
83. Joffe R T, et al. Subclinical hypothyroidism, mood, and cognition in older adults: a review. Int J Geriatr Psychiatry 2012.
84. Villaverde Gutierrez C, et al. Influence of exercise on mood in postmenopausal women. J Clin Nurs 2012;21(7-8):923-8.
85. Khoshbooii R, et al. Effectiveness of group cognitive behavioral therapy on depression among Iranian women around menopause. Aust J Basic Appl Sci 2011;5(11):991-5.
86. Kornstein SG, et al. The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women. Menopause 2010;17(4):828-39.
87. Morrison M F, et al. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004;55(4):406-12. (Pubitemid 38199991)
88. Parry BL. Optimal management of perimenopausal depression. Int J Womens Health 2010;2:143-51.
89. Lipovac M, et al. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 2010;65(3):258-61.
90. Wong VC, et al. Current alternative and complementary therapies used in menopause. Gynecol Endocrinol 2009;25(3): 166-74.